Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MELINA ELPI MARMARELIS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1346688793
CMS profile
856967
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$68,386.92

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,663.85

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $14,139.50 8
Food and Beverage $361.35 5
Travel and Lodging $163.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,338.35 9
PY2019 $8,569.15 12
PY2020 $4,158.50 3
PY2021 $3,909.99 4
PY2022 $10,044.95 9
PY2023 $6,702.13 14
PY2024 $14,663.85 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $50.00 09/06/2024 Food and Beverage Undisputed 01/23/2026 1104238661 CMS
AstraZeneca Pharmaceuticals LP $832.50 09/23/2024 Consulting Fee Undisputed 01/23/2026 1105682079 CMS
AstraZeneca UK Limited $1,665.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1093954898 CMS
Daiichi Sankyo Inc. $34.76 02/23/2024 Food and Beverage Undisputed 01/23/2026 1089452498 CMS
Daiichi Sankyo Inc. $555.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1089452496 CMS
E.R. Squibb & Sons, L.L.C. $50.00 09/08/2024 Food and Beverage Undisputed 01/23/2026 1101444137 CMS
E.R. Squibb & Sons, L.L.C. $2,400.00 09/19/2024 Consulting Fee Undisputed 01/23/2026 1101444068 CMS
Janssen Biotech, Inc. $84.20 02/26/2024 Food and Beverage Undisputed 01/23/2026 1078585249 CMS
Janssen Biotech, Inc. $142.39 04/19/2024 Food and Beverage Undisputed 01/23/2026 1078582088 CMS
Janssen Research & Development, LLC $390.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 1077590177 CMS
Janssen Scientific Affairs, LLC $2,025.00 08/27/2024 Consulting Fee Undisputed 01/23/2026 1078857914 CMS
Regeneron Pharmaceuticals, Inc. $4,704.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114402397 CMS
Regeneron Pharmaceuticals, Inc. $1,568.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114402399 CMS
Regeneron Pharmaceuticals, Inc. $163.00 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114402401 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.